Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 120-130

  Omoto, Shinya ^a   Mocarski, Edward S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UL115 PROTEIN; UL32 PROTEIN; UL44 PROTEIN; UL55 PROTEIN; UL73 PROTEIN; UL75 PROTEIN; UL80 PROTEIN; UL82 PROTEIN; UL83 PROTEIN; UL86 PROTEIN; UL91 PROTEIN; UL92 PROTEIN; UL99 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BACTERIOPHAGE; BETAHERPESVIRINAE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPLASM; DNA REPLICATION; DNA SYNTHESIS; GAMMAHERPESVIRINAE; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRION; VIRUS CAPSID; VIRUS GENE; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOMEGALOVIRUS; DNA PRIMERS; DNA REPLICATION; DNA, VIRAL; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 84890875583     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02983-13     Document Type: Article

References (70)

1. Mocarski ES, Jr, Shenk T, Griffith P, Pass RF. 2013. Cytomegaloviruses, p 1960-2014. In Knipe DM, Howley PM (ed), Fields virology, 6th ed. Lippincott/The Williams & Wilkins Co, Philadelphia, PA.
2. Liu B, Stinski MF. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
3. Cantrell SR, Bresnahan WA. 2005. Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate- early gene expression and viral replication. J. Virol. 79:7792-7802. http://dx.doi.org/10.1128/JVI.79.12.7792-7802.2005.
4. Bresnahan WA, Shenk TE. 2000. UL82 virion protein activates expression of immediate-early viral genes in human cytomegalovirus-infected cells Proc. Natl. Acad. Sci. U. S. A. 97:14506-14511. http://dx.doi.org/10 .1073/pnas.97.26.14506.
5. Lukashchuk V, McFarlane S, Everett RD, Preston CM. 2008. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82: 12543-12554. http://dx.doi.org/10.1128/JVI.01215-08.
6. Tavalai N, Stamminger T. 2010. Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res. 157:128-133.
7. Stinski MF, Petrik DT. 2008. Functional roles of the human cytomegalovirus essential IE86 protein. Curr. Top. Microbiol. Immunol. 325:133- 152. http://dx.doi.org/10.1007/978-3-540-77349-8_8.
8. Greaves RF, Mocarski ES. 1998. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:366-379.
9. Gawn JM, Greaves RF. 2002. Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J. Virol. 76:4441-4455. http: //dx.doi.org/10.1128/JVI.76.9.4441-4455.2002.
10. Stinski MF, Meier JL. 2007. Immediate-early CMV gene regulation and function, p 241-263. In Arvin AM, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge Press, Cambridge, United Kingdom.
11. White EA, Spector DH. 2007. Early CMV gene expression and function, p 264-294. In Arvin AM, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy and immunoprophylaxis. Cambridge Press, Cambridge, United Kingdom.
12. Marshall EE, Bierle CJ, Brune W, Geballe AP. 2009. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J. Virol. 83: 4112-4120. http://dx.doi.org/10.1128/JVI.02489-08.
13. Brune W. 2011. Inhibition of programmed cell death by cytomegaloviruses. Virus Res. 157:144-150. http://dx.doi.org/10.1016/j.virusres.2010.10.012.
14. McCormick AL, Mocarski ES. 2013. Cell death pathways controlled by cytomegaloviruses, p 263-276. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, vol I. Caister Scientific Press, Norfolk, United Kingdom.
15. Reeves MB. 2011. Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res. 157:134-143. http://dx.doi.org/10.1016/j.virusres.2010.09.019.
16. Mocarski ES, Upton JW, Kaiser WJ. 2011. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12:79-88. http://dx.doi.org/10.1038/nrg2945.
17. Ishov AM, Maul GG. 1996. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134:815-826. http://dx.doi.org/10.1083/jcb.134.4.815.
18. Ishov AM, Stenberg RM, Maul GG. 1997. Human cytomegalovirus immediate-early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 138:5-16. http://dx.doi.org/10.1083/jcb.138.1.5.
19. Anders DG, Kerry JA, Pari GS. 2007. CMV DNA synthesis and late viral gene expression, p 295-310. In Arvin AM, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge Press, Cambridge, United Kingdom.
20. Pari GS. 2008. Nuts and bolts of human cytomegalovirus lytic DNA replication. Curr. Top. Microbiol. Immunol. 325:153-166. http://dx.doi.org /10.1007/978-3-540-77349-8_9.
21. Kim YE, Ahn JH. 2010. Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase processivity factor in promoting DNA replication of human cytomegalovirus. J. Virol. 84:8409-8421. http://dx.doi.org/10.1128/JVI.00189-10.
22. Kagele D, Rossetto CC, Tarrant MT, Pari GS. 2012. Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt. Virology 424:106-114. http://dx.doi.org/10.1016/j.virol.2011.12.010.
23. Tandon R, Mocarski ES. 2012. Viral and host control of cytomegalovirus maturation. Trends Microbiol. 20:392-401. http://dx.doi.org/10.1016/j.tim.2012.04.008.
24. Mocarski ES. 2007. Betaherpes viral genes and their functions, p 204-230. In Arvin AM, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, Whitley R, YamanishiK(ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge Press, Cambridge, United Kingdom.
25. Adam BL, Jervey TY, Kohler CP, Wright GL, Jr, Nelson JA, Stenberg RM. 1995. The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J. Virol. 69:5304-5310.
26. Wing BA, Huang ES. 1995. Analysis and mapping of a family of 3=- coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol. 69:1521-1531.
27. Wing BA, Johnson RA, Huang ES. 1998. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J. Virol. 72:1814-1825.
28. Leatham MP, Witte PR, Stinski MF. 1991. Alternate promoter selection within a human cytomegalovirus immediate-early and early transcription unit (UL119-115) defines true late transcripts containing open reading frames for putative viral glycoproteins. J. Virol. 65:6144-6153.
29. McWatters BJ, Stenberg RM, Kerry JA. 2002. Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. Virology 303:309-316. http://dx.doi.org/10.1006/viro.2002.1614.
30. Wang SK, Duh CY, Wu CW. 2004. Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J. Virol. 78:9750-9762. http://dx.doi.org/10.1128/JVI.78.18.9750 -9762.2004.
31. Sanchez V, Greis KD, Sztul E, Britt WJ. 2000. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J. Virol. 74:975-986. http://dx.doi.org/10.1128 /JVI.74.2.975-986.2000.
32. Perng YC, Qian Z, Fehr AR, Xuan B, Yu D. 2011. Human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. J. Virol. 85:4841-4852. http://dx.doi.org/10.1128/JVI.02344-10.
33. Leach FS, Mocarski ES. 1989. Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J. Virol. 63:1783-1791.
34. Isomura H, Stinski MF, Kudoh A, Nakayama S, Iwahori S, Sato Y, Tsurumi T. 2007. The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis. J. Virol. 81:6197- 6206. http://dx.doi.org/10.1128/JVI.00089-07.
35. Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, Sato Y, Iwahori S, Tsurumi T. 2008. Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. J. Virol. 82:1638-1646. http://dx.doi.org/10.1128/JVI.01917-07.
36. White EA, Del Rosario CJ, Sanders RL, Spector DH. 2007. The IE2 60-kilodalton and 40-kilodalton proteins are dispensable for human cytomegalovirus replication but are required for efficient delayed early and late gene expression and production of infectious virus. J. Virol. 81:2573- 2583. http://dx.doi.org/10.1128/JVI.02454-06.
37. Gatherer D, Seirafian S, Cunningham C, Holton M, Dargan DJ, Baluchova K, Hector RD, Galbraith J, Herzyk P, Wilkinson GW, Davison AJ. 2011. High-resolution human cytomegalovirus transcriptome. Proc. Natl. Acad. Sci. U. S. A. 108:19755-19760. http://dx.doi.org/10.1073/pnas.1115861108.
38. Kohler CP, Kerry JA, Carter M, Muzithras VP, Jones TR, Stenberg RM. 1994. Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J. Virol. 68:6589- 6597.
39. Kerry JA, Priddy MA, Kohler CP, Staley TL, Weber D, Jones TR, Stenberg RM. 1997. Translational regulation of the human cytomegalovirus pp28 (UL99) late gene. J. Virol. 71:981-987.
40. Homa FL, Glorioso JC, Levine M. 1988. A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev. 2:40-53. http://dx.doi.org/10.1101/gad.2.1.40.
41. Jahn G, Kouzarides T, Mach M, Scholl BC, Plachter B, Traupe B, Preddie E, Satchwell SC, Fleckenstein B, Barrell BG. 1987. Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J. Virol. 61:1358-1367.
42. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GW, Davison AJ. 2004. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85:1301- 1312. http://dx.doi.org/10.1099/vir.0.79888-0.
43. Davison AJ, Bhella D. 2007. Comparative betaherpesviral genome and virion structure, p 177-203. In Arvin AM, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge Press, Cambridge, United Kingdom.
44. Arumugaswami V, Wu TT, Martinez-Guzman D, Jia Q, Deng H, Reyes N, Sun R. 2006. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 80:9730-9740. http://dx.doi.org/10.1128/JVI.00246-06.
45. Jia Q, Wu TT, Liao HI, Chernishof V, Sun R. 2004. Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J. Virol. 78:6610-6620. http://dx.doi.org/10.1128/JVI.78.12.6610-6620.2004.
46. Wong E, Wu TT, Reyes N, Deng H, Sun R. 2007. Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J. Virol. 81:6761-6764. http://dx.doi.org/10.1128/JVI.02726-06.
47. Wu TT, Park T, Kim H, Tran T, Tong L, Martinez-Guzman D, Reyes N, Deng H, Sun R. 2009. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J. Virol. 83:2265-2273. http://dx.doi.org/10.1128/JVI.01785-08.
48. Wyrwicz LS, Rychlewski L. 2007. Identification of herpes TATT-binding protein. Antivir. Res. 75:167-172. http://dx.doi.org/10.1016/j.antiviral.2007.03.002.
49. Gruffat H, Kadjouf F, Mariame B, Manet E. 2012. The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J. Virol. 86:6023-6032. http://dx.doi.org/10.1128/JVI.00159-12.
50. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228. http://dx.doi.org/10.1073/pnas.2334032100.
51. Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401. http://dx.doi.org/10.1073/pnas.1635160100.
52. Isomura H, Stinski MF, Murata T, Yamashita Y, Kanda T, Toyokuni S, Tsurumi T. 2011. The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J. Virol. 85:6629-6644. http://dx.doi.org/10.1128/JVI.00384-11.
53. Omoto S, Mocarski ES. 2013. Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J. Virol. 87:8651-8664. http://dx.doi.org/10.1128/JVI.01052-13.
54. Geiduschek EP, Kassavetis GA. 2010. Transcription of the T4 late genes. Virol. J. 7:288. http://dx.doi.org/10.1186/1743-422X-7-288.
55. Searles RP, Bergquam EP, Axthelm MK, Wong SW. 1999. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73:3040-3053.
56. Alexander L, Denekamp L, Knapp A, Auerbach MR, Damania B, Desrosiers RC. 2000. The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J. Virol. 74: 3388-3398. http://dx.doi.org/10.1128/JVI.74.7.3388-3398.2000.
57. Rawlinson WD, Farrell HE, Barrell BG. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
58. Brocchieri L, Kledal TN, Karlin S, Mocarski ES. 2005. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79:7570-7596. http://dx.doi.org/10.1128/JVI.79.12.7570-7596.2005.
59. Yu D, Chapa TJ, Perng Y-C, French A. 2014. Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression. J. Virol. 88:131-142. http://dx.doi.org/10.1128/JVI.02684-13.
60. Marchini A, Liu H, Zhu H. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878. http://dx.doi.org/10.1128/JVI.75.4.1870-1878.2001.
61. Hansen SG, Strelow LI, Franchi DC, Anders DG, Wong SW. 2003. Complete sequence and genomic analysis of rhesus cytomegalovirus. J. Virol. 77:6620-6636. http://dx.doi.org/10.1128/JVI.77.12.6620-6636.2003.
62. Rivailler P, Kaur A, Johnson RP, Wang F. 2006. Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhe- sus cytomegalovirus. J. Virol. 80:4179-4182. http://dx.doi.org/10.1128/JVI.80.8.4179-4182.2006.
63. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 93:11382-11388. http://dx.doi.org/10.1073/pnas.93.21.11382.
64. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. http://dx.doi.org/10.1093/nar/gni035.
65. McCormick AL, Roback L, Wynn G, Mocarski ES. 2013. Multiplicitydependent activation of a serine protease-dependent cytomegalovirusassociated programmed cell death pathway. Virology 435:250-257. http://dx.doi.org/10.1016/j.virol.2012.08.042.
66. Chee M, Rudolph SA, Plachter B, Barrell B, Jahn G. 1989. Identification of the major capsid protein gene of human cytomegalovirus. J. Virol. 63:1345-1353.
67. Tandon R, Mocarski ES. 2011. Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J. Virol. 85:7129-7141. http://dx.doi.org/10.1128/JVI.02549-10.
68. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, Mann M, Ingolia NT, Weissman JS. 2012. Decoding human cytomegalovirus. Science 338:1088- 1093. http://dx.doi.org/10.1126/science.1227919.
69. Isomura H, Stinski MF. 2013. Coordination of late gene transcription of human cytomegalovirus with viral DNA synthesis: recombinant viruses as potential therapeutic vaccine candidates. Expert opinion on therapeutic targets. 17:157-166. http://dx.doi.org/10.1517/14728222.2013.740460.
70. Gibson W. 2006. Assembly and maturation of the capsid, p 231-244. In Reddehase MJ (ed), Cytomegaloviruses: pathogenesis, molecular biology, and infection control. Caister Scientific Press, Norfolk, United Kingdom.